Company profile: Veryan Medical
1.1 - Company Overview
Company description
- Provider of three-dimensional Nitinol vascular stents for peripheral arterial disease, including the BioMimics 3D Vascular Stent System, a self-expanding stent with 3D helical geometry designed to impart a gentle helical shape to the stented artery to provoke swirling flow, increase wall shear stress, reduce intimal hyperplasia, improve biomechanical compatibility, and reduce stent fracture risk, and the MIMICS clinical program (MIMICS-RCT, MIMICS-2, MIMICS-3D) evaluating safety, effectiveness, and performance.
Products and services
- BioMimics 3D Nitinol Stent Technology: A patented 3D helical design platform created from Imperial College spin-out work to shape peripheral arteries, induce swirling flow, elevate wall shear stress, and mitigate intimal hyperplasia and fracture
- BioMimics 3D Vascular Stent System: A peripheral self-expanding Nitinol (nickel-titanium alloy) stent with 3D helical geometry that imparts helicity, provokes swirling flow raising wall shear, lessens intimal hyperplasia, improves biomechanical compatibility, and reduces fracture risk
- MIMICS Clinical Programme: A multi-study clinical framework encompassing MIMICS-RCT, MIMICS-2, and MIMICS-3D to rigorously assess safety, effectiveness, and performance of BioMimics 3D in diverse peripheral arterial patient populations and scenarios
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Veryan Medical
Micro Interventional Devices
HQ: United States
Website
- Description: Provider of percutaneous and minimally invasive structural heart repair technologies, including PolyCor polymeric anchors for soft-tissue cardiac applications; the MIA-T and MIA-M percutaneous annuloplasty systems for tricuspid and mitral valve regurgitation; and the Transcatheter Cardiac Repair platform enabling catheter-based treatment of structural heart disease without cardiopulmonary bypass.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micro Interventional Devices company profile →
TVA Medical
HQ: United States
Website
- Description: Provider of minimally invasive medical device therapies for end-stage renal disease, including the WavelinQ EndoAVF System, which creates endovascular arteriovenous fistulas for hemodialysis access using a non-surgical approach with magnetic catheters and radiofrequency energy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TVA Medical company profile →
Baylis Medical
HQ: Canada
Website
- Description: Provider of high-technology cardiology, endovascular, and oncology products, specializing in RF transseptal access and puncture systems that create controlled perforations in cardiac and vascular tissues. Products include NRG RF Transseptal Kit and Needle, SupraCross RF Transseptal Solution, VersaCross steerable access solutions, and SureFlex steerable guiding sheaths.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baylis Medical company profile →
Direct Flow Medical
HQ: United States
Website
- Description: Provider of medical implants used in the treatment of aortic and heart valve diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Direct Flow Medical company profile →
Myogen
HQ: United States
Website
- Description: Provider of small molecule therapeutics for cardiovascular disorders, focused on the discovery, development and commercialization of treatments, combining advanced understanding of cardiovascular disease biology with clinical development expertise in cardiovascular therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myogen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Veryan Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Veryan Medical
2.2 - Growth funds investing in similar companies to Veryan Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Veryan Medical
4.2 - Public trading comparable groups for Veryan Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →